Resolvins, docosatrienes, and neuroprotectins, novel omega‐3‐derived mediators, and their endogenous aspirin‐triggered epimers

Lipids - 2004
Charles N. Serhan1, Makoto Arita1, Song Hong1, Katherine Gotlinger1
1Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St., Thorn Building for Medical Research, Room 724, Boston, Massachusetts, 02115

Tóm tắt

Abstract

The molecular basis for the beneficial impact of essential omega‐3 (n−3) FA remains of interest. Recently, we identified novel mediators generated from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that displayed potent bioactions identified first in resolving inflammatory exudates and in tissues enriched with DHA. The trivial names resolvin (resolution phase interaction products) and docosatrienes were introduced for the bioactive compounds from these novel series since they possess potent anti‐inflammatory and immunoregulatory actions. Compounds derived from EPA carrying potent biological actions (i.e., 1–10 nM range) are designated E series and denoted resolvins of the E series (resolvin E1 or RvE1), and those biosynthesized from the precursor DHA are denoted resolvins of the D series (resolvin D1 or RvD1). The number 1 designates the bioactive compounds in this family (e.g., 1–4). Bioactive members from DHA‐containing conjugated triene structures or docosatrienes (DT) that possess immunoregulatory and neuroprotective actions were termed neuroprotectins. Aspirin treatment initiates a related epimeric series by triggering endogenous formation of the 17R‐D series resolvins and docosatrienes. These epimers are denoted as aspirin‐triggered (AT)‐RvD and DT, and possess potent anti‐in‐flammatory actions in vivo essentially equivalent to their 17S series pathway products. These include five distinct series: (i) 18R resolvins from EPA (i.e., RvE1); (ii) 17R series (AT) resolvins from DHA (RvD1 through RvD4); (iii) 17S series resolvins from DHA (RvD1 through RvD4), (iv) DT from DHA; and (v) their AT form 17R series DT. In this article, we provide an overview of the formation and actions of these newly uncovered pathways and products.

Từ khóa


Tài liệu tham khảo

10.1016/S0021-9258(20)78281-5

Lands W.E.M., 1987, Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids

Bazan N.G., 1990, Nutrition and the Brain, 1

10.1080/07315724.1999.10718888

10.1007/s11745-001-0805-6

10.1038/ng1311

10.1001/jama.291.5.585

10.1001/jama.291.5.623

Gallin J.I., 1999, Inflammation: Basic Principles and Clinical Correlates, 1360

10.1177/154405910308200202

10.1084/jem.192.8.1197

10.1084/jem.20020760

10.1074/jbc.M300218200

10.1074/jbc.M305841200

10.1073/pnas.0402531101

Lehr H.‐A., 1994, P‐Selectin Mediates the Interaction of Circulating Leukocytes with Platelets and Microvascular Endothelium in Response to Oxidized Lipoprotein in vivo, Lab. Invest., 71, 380

10.1038/nature01726

10.1073/pnas.81.17.5335

10.1172/JCI114503

Marcus A.J., 1999, Inflammation: Basic Principles and Clinical Correlates, 77

10.1016/S0021-9258(18)41982-5

10.1084/jem.180.1.253

10.1124/mol.64.3.721

10.4049/jimmunol.168.10.5260

10.1084/jem.183.1.137

10.4049/jimmunol.164.4.1663

10.1073/pnas.92.21.9475

10.1038/nm786

10.1126/science.1071702

10.1126/science.1068711

10.4049/jimmunol.170.5.2688

10.1124/jpet.300.2.385

10.1046/j.1523-1755.2003.00106.x

10.1096/fj.02-0770com

10.4049/jimmunol.171.12.6856

10.1056/NEJM198007033030109

Samuelsson B., 1982, Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures, 153

Vane J.R., 1982, Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures, 181

10.1016/S0140-6736(99)07072-5

10.1161/01.CIR.0000014682.14181.F2

10.1016/S0952-3278(02)00272-7

Bazan N.G., 1992, Supply, Uptake, and Utilization of Docosahexaenoic Acid During Photoreceptor Cell Differentiation, Nestle Nutrition Workshop Series, 28, 121

10.1172/JCI111612

10.1046/j.1471-4159.1994.62062437.x

10.1021/bi992000l

10.1016/S0021-9258(18)91081-1

10.1007/s11745-003-1066-0

10.1385/1592593747

Lu Y. Hong S. Tjonahen E. andSerhan C.N.(2003)Lipid Mediator Lipidomics: Databases and Search Algorithms of Electric Spray Ionization/Tandem Mass and Ultraviolet Spectra for Structural Elucidation Paper presented at the 5th Winter Eicosanoid Conference Baltimore March 9‐‐12.

10.1074/jbc.271.37.22663

Arita M. Bianchini F. Aliberti J. Sher A. Chiang N. Hong S. Yang R. Tetasis N.A. andSerhan C.N.(2005)Stereo‐chemical Assignment Antiinflammatory Properties and Receptor for the Omega‐3 Lipid Mediator Resolvin E1 J. Exp. Med. in press.

10.1073/pnas.80.12.3581

10.1172/JCI13375

10.1073/pnas.0406727101

10.2135/cropsci2002.1695

Rådmark O.(2002)Arachidonate 5‐Lipoxygenase Prostaglandins Other lipid Mediat.68‐‐69 211–234.

Funk C.D. Chen X.S. Johnson E.N. andZhao L.(2002)Lipoxygenase Genes and Their Targeted Disruption Prostaglandins Other Lipid Mediat.68‐‐69 303–312.

10.1016/S0014-5793(99)00396-8

Furstenberger G. Marks F. andKrieg P.(2002)Arachidonate 8(S)‐Lipoxygenase Prostaglandins Other Lipid Mediat.68‐‐69 235–243.

10.1073/pnas.0307308101

10.1021/bi00170a002

Thông tin
Thông tin xuất bản

Lipids

Thông tin tác giả